Global Infectious Disease Diagnostics Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

November 2017 | 197 pages | ID: G06CEBACF1EEN
Precision Business Insights (PBI)

Abstracts

Global Infectious Disease Diagnostics Market

Infectious disease diagnostics are the procedures for identification and characterization of the causative agent of an infectious disease with the aid of diagnostic tools. These diagnostics provide crucial information for making right medical decisions. Infectious diseases caused by various micro-organisms such as viruses, bacteria, fungi, and parasites. Infectious diseases transmitted from person to person through either indirect or direct contact. Infectious diseases such as bacterial infections, fungal infections, and viral infections such as respiratory diseases, HPV, HIV, measles, malaria, dengue, cholera, and hepatitis B and C are gradually spreading worldwide. Infectious disease diagnostics can be based solely on clinical presentation or more rigorous diagnostic tests, such as microscopy, biochemical screens, culturing of an infectious agent, and molecular methods.

The key drivers for the growth of the infectious disease diagnostics market increase in the prevalence of dengue, malaria, and HIV, rise in the preference for rapid diagnosis, increase in government funding for the establishment of diagnostic centers, and technological advancements in diagnostic procedures expected to fuel the infectious disease diagnostics market. Furthermore, increase in the R&D activities for newer assays, changing demographics around the globe, and advances in healthcare infrastructure are expected to boost the infectious disease diagnostics market. However, high cost for the diagnostic procedures, lack of awareness about the novel diagnostic procedures, dearth of skilled professionals to perform diagnostic tests, and lack of reimbursement policies for several diagnostic test might hamper the infectious disease diagnostics market growth over the forecast period.

The infectious disease diagnostics market has been segmented on the basis of test type, technique type, product type, infection type, and the end-user

Based on the test type, infectious disease diagnostics market has been segmented into following:

• Imaging test
• Magnetic Resonance Imaging (MRI)
• X-ray
• Computed tomography (C.T)
• Laboratory tests
• Blood test
• Urine test
• Stool test
• Spinal tap
• Throat swabs
• Biopsies
• Others

Based on the product type, infectious disease diagnostics market has been segmented into following:

• Assay kits and consumables
• Instruments
• Services

Based on the infection type, infectious disease diagnostics market has been segmented into following:

• Viral
• Bacterial
• CNS
• Fungal
• Cardiovascular
• Sexually transmitted infectious diseases
• Gastrointestinal
• Others

Based on the end-user, the infectious disease diagnostics market has been segmented into following:

• Hospitals
• Diagnostic laboratories
• Home healthcare
• Ambulatory clinics
• Others

Geographically, the global infectious disease diagnostics market is in the flourishing stage, with the development of novel technologies by various players in the market. Increasing prevalence of the deadly infectious disease will drive the growth of the global infectious disease diagnostics market over the forecast period. For instance, according to World Health Organisation, global health observatory (GHO) data, in 2013, approximately 34-38 million people suffered from HIV infection worldwide. Innovation of technologically advanced devices with quick results, ease of usage, accuracy, and low-cost are expected to boost global infectious disease diagnostics market. For instance, in 2013, Abbott Molecular introduced a new range of real-time assays for hepatitis B virus, and hepatitis C virus infections on its m2000 platform. The majority of companies are making efforts to develop and commercialize cost-effective tools for the infectious disease diagnostics. Nowadays, the gold standard tests available for sexually transmitted disease and bacterial infection diagnosis, and these tests are expected to replace by molecular techniques in future.

Geographically, global infectious disease diagnostics market has been segmented into following regions Viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America dominates the global infectious disease diagnostics market followed by Europe and Asia-Pacific. The largest share of North-America region is due to increase in the prevalence of infectious diseases especially in U.S. According to UNAIDS, in 2012, about 1.3 Mn patients were diagnosed with HIV in the U.S. These statistics are likely to increase over the coming years, if suitable treatment options are not provided in time. The European region is expected to emerge as significant market owing to improved healthcare infrastructure, and increase in prevalence of bacterial and viral diseases (according to WHO European Region, at the end of 2015, about 13.3 Mn people live with chronic hepatitis B, an estimated 15 Mn people with hepatitis C, and more than 2 Mn people with HIV), which are expected to fuel the growth of the infectious disease diagnostics market in European region. Moreover, Asia-Pacific is a key region for the growth of global infectious disease diagnostics during the forecast period, due to the high prevalence of infectious diseases, and increasing in healthcare expenditure. Moreover, due to increase in incidence and prevalence of infectious diseases such as bacterial infections and sexually transmitted diseases and rise in population expected to drive significant growth of the infectious disease diagnostics market in Asia-Pacific region.

Some of the players in global infectious disease diagnostics market are F. Hoffmann-La Roche Ltd. (Switzerland), bioMérieux SA (France), Thermo Fischer Scientific (U.S.), Abbott Laboratories (U.S.), Bio-Rad Laboratories Inc. (U.S.), Becton, Dickinson & Company (U.S.), and DiaSorin S.p.A. (Italy) to name a few.

In 2016, Abbott unveiled Alinity, its unified family of innovative next-generation diagnostics system across immunoassay, clinical chemistry, point of care, hematology, blood and plasma screening, and molecular diagnostics

In 2015, Bio-Rad FDA has approved Bio-Rad’s BioPlex 2200 human immunodeficiency virus (HIV) Antigen-Antibody assay, used for detection of HIV antibodies and HIV antigens

In 2014, DiaSorin launched the new molecular diagnostic test for the detection of Toxoplasmosis

REPORT OUTLINE:

• The report provides granular level information about the market size, regional market share and forecast from 2017-2023
• The report covers in-detail insights about the competitor’s overview, key findings and their key strategies
• The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry
• The report tracks recent innovations, key developments and startup’s details that are working in the industry
• The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario

Contents

1. EXECUTIVE SUMMARY

2. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET INTRODUCTION

2.1. Global Infectious Disease Diagnostics Market– Taxonomy
2.2. Global Infectious Disease Diagnostics Market–Definitions
  2.2.1. Test Type
  2.2.2. Product Type

3. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET DYNAMICS

3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Infectious Disease Diagnostics Market Dynamics – Factors Impact Analysis
3.6. Global Infectious Disease Diagnostics Market– Recent Product Launches

4. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023

4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis

5. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023

5.1. Imaging Test
  5.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.1.3. Market Opportunity Analysis
5.2. Magnetic Resonance Imaging (MRI)
  5.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.2.3. Market Opportunity Analysis
5.3. Laboratory Tests
  5.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.3.3. Market Opportunity Analysis
5.4. Biopsies
  5.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.4.3. Market Opportunity Analysis
5.5. Others
  5.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.5.3. Market Opportunity Analysis

6. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET FORECAST, BY PRODUCT TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023

6.1. Assay Kits and Consumables
  6.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.1.3. Market Opportunity Analysis
6.2. Instruments
  6.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.2.3. Market Opportunity Analysis
6.3. Services
  6.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.3.3. Market Opportunity Analysis

7. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET FORECAST, BY INFECTION TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023

7.1. Viral
  7.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.1.3. Market Opportunity Analysis
7.2. Bacterial
  7.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.2.3. Market Opportunity Analysis
7.3. Fungal
  7.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.3.3. Market Opportunity Analysis
7.4. Sexually Transmitted Infectious Diseases
  7.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.4.3. Market Opportunity Analysis
7.5. Gastrointestinal
  7.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.5.3. Market Opportunity Analysis
7.6. Others
  7.6.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.6.3. Market Opportunity Analysis

8. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET FORECAST, BY END USER, 2012 - 2016 AND FORECAST, 2017 - 2023

8.1. Hospitals
  8.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.1.3. Market Opportunity Analysis
8.2. Diagnostic laboratories
  8.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.2.3. Market Opportunity Analysis
8.3. Home Healthcare
  8.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.3.3. Market Opportunity Analysis
8.4. Ambulatory Clinics
  8.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.4.3. Market Opportunity Analysis
8.5. Others
  8.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.5.3. Market Opportunity Analysis

9. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET FORECAST, BY REGION, 2012 - 2016 AND FORECAST, 2017 - 2023

9.1. North America
  9.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  9.1.3. Market Opportunity Analysis
9.2. Europe
  9.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
  9.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  9.3.3. Market Opportunity Analysis
9.4. Latin America
  9.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
  9.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  9.5.3. Market Opportunity Analysis
9.6. Global Infectious Disease Diagnostics Market- Opportunity Analysis Index - By Test Type, By Product Type, By Infection Type, By End User, and Region, 2017 – 2023

10. NORTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

  10.1.1. Test Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
    10.1.1.1. Imaging Test
    10.1.1.2. Magnetic Resonance Imaging (MRI)
    10.1.1.3. X-ray
    10.1.1.4. Computed tomography (C.T)
    10.1.1.5. Laboratory Tests
      10.1.1.5.1. Blood Tests
      10.1.1.5.2. Urine Tests
      10.1.1.5.3. Stool Tests
      10.1.1.5.4. Spinal Tap
      10.1.1.5.5. Throat Swabs
    10.1.1.6. Biopsies
    10.1.1.7. Others
  10.1.2. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    10.1.2.1. Assay Kits and Consumables
    10.1.2.2. Instruments
    10.1.2.3. Services
  10.1.3. Infection Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    10.1.3.1. Viral
    10.1.3.2. Bacterial
    10.1.3.3. Fungal
    10.1.3.4. Sexually Transmitted Infectious Diseases
    10.1.3.5. Gastrointestinal
    10.1.3.6. Others
  10.1.4. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    10.1.4.1. Hospitals
    10.1.4.2. Diagnostic laboratories
    10.1.4.3. Home Healthcare
    10.1.4.4. Ambulatory Clinics
    10.1.4.5. Others
  10.1.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
    10.1.5.1. U.S.
    10.1.5.2. Canada
  10.1.6. North America Infectious Disease Diagnostics Market- Opportunity Analysis Index - By Test Type, By Product Type, By Infection Type, By End User, and Country, 2017 – 2023
  10.1.7. North America Infectious Disease Diagnostics Market Dynamics – Trends

11. EUROPE INFECTIOUS DISEASE DIAGNOSTICS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

  11.1.1. Test Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
    11.1.1.1. Imaging Test
    11.1.1.2. Magnetic Resonance Imaging (MRI)
    11.1.1.3. X-ray
    11.1.1.4. Computed tomography (C.T)
    11.1.1.5. Laboratory Tests
      11.1.1.5.1. Blood Tests
      11.1.1.5.2. Urine Tests
      11.1.1.5.3. Stool Tests
      11.1.1.5.4. Spinal Tap
      11.1.1.5.5. Throat Swabs
    11.1.1.6. Biopsies
    11.1.1.7. Others
  11.1.2. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    11.1.2.1. Assay Kits and Consumables
    11.1.2.2. Instruments
    11.1.2.3. Services
  11.1.3. Infection Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    11.1.3.1. Viral
    11.1.3.2. Bacterial
    11.1.3.3. Fungal
    11.1.3.4. Sexually Transmitted Infectious Diseases
    11.1.3.5. Gastrointestinal
    11.1.3.6. Others
  11.1.4. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    11.1.4.1. Hospitals
    11.1.4.2. Diagnostic laboratories
    11.1.4.3. Home Healthcare
    11.1.4.4. Ambulatory Clinics
    11.1.4.5. Others
  11.1.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    11.1.5.1. Germany
    11.1.5.2. UK
    11.1.5.3. France
    11.1.5.4. Spain
    11.1.5.5. Italy
    11.1.5.6. Russia
    11.1.5.7. Poland
    11.1.5.8. Rest of Europe
  11.1.6. Europe Infectious Disease Diagnostics Market- Opportunity Analysis Index - By Test Type, By Product Type Type, By Infection Type, By End User, and Country, 2017 – 2023
  11.1.7. Europe Infectious Disease Diagnostics Market Dynamics – Trends

12. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

  12.1.1. Test Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
    12.1.1.1. Imaging Test
    12.1.1.2. Magnetic Resonance Imaging (MRI)
    12.1.1.3. X-ray
    12.1.1.4. Computed tomography (C.T)
    12.1.1.5. Laboratory Tests
      12.1.1.5.1. Blood Tests
      12.1.1.5.2. Urine Tests
      12.1.1.5.3. Stool Tests
      12.1.1.5.4. Spinal Tap
      12.1.1.5.5. Throat Swabs
    12.1.1.6. Biopsies
    12.1.1.7. Others
  12.1.2. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    12.1.2.1. Assay Kits and Consumables
    12.1.2.2. Instruments
    12.1.2.3. Services
  12.1.3. Infection Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    12.1.3.1. Viral
    12.1.3.2. Bacterial
    12.1.3.3. Fungal
    12.1.3.4. Sexually Transmitted Infectious Diseases
    12.1.3.5. Gastrointestinal
    12.1.3.6. Others
  12.1.4. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    12.1.4.1. Hospitals
    12.1.4.2. Diagnostic laboratories
    12.1.4.3. Home Healthcare
    12.1.4.4. Ambulatory Clinics
    12.1.4.5. Others
  12.1.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn),
Y-o-Y Growth (%), and Market Share (%)
    12.1.5.1. Japan
    12.1.5.2. China
    12.1.5.3. India
    12.1.5.4. ASEAN
    12.1.5.5. Australia & New Zealand
    12.1.5.6. Rest of Asia-Pacific
  12.1.6. Asia-Pacific Infectious Disease Diagnostics Market- Opportunity Analysis Index - By Test Type, By Product Type Type, By Infection Type, By End User, and Country, 2017 – 2023
  12.1.7. Asia-Pacific Infectious Disease Diagnostics Market Dynamics – Trends

13. LATIN AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

  13.1.1. Test Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
    13.1.1.1. Imaging Test
    13.1.1.2. Magnetic Resonance Imaging (MRI)
    13.1.1.3. X-ray
    13.1.1.4. Computed tomography (C.T)
    13.1.1.5. Laboratory Tests
      13.1.1.5.1. Blood Tests
      13.1.1.5.2. Urine Tests
      13.1.1.5.3. Stool Tests
      13.1.1.5.4. Spinal Tap
      13.1.1.5.5. Throat Swabs
    13.1.1.6. Biopsies
    13.1.1.7. Others
  13.1.2. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    13.1.2.1. Assay Kits and Consumables
    13.1.2.2. Instruments
    13.1.2.3. Services
  13.1.3. Infection Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    13.1.3.1. Viral
    13.1.3.2. Bacterial
    13.1.3.3. Fungal
    13.1.3.4. Sexually Transmitted Infectious Diseases
    13.1.3.5. Gastrointestinal
    13.1.3.6. Others
  13.1.4. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    13.1.4.1. Hospitals
    13.1.4.2. Diagnostic laboratories
    13.1.4.3. Home Healthcare
    13.1.4.4. Ambulatory Clinics
    13.1.4.5. Others
  13.1.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    13.1.5.1. Brazil
    13.1.5.2. Mexico
    13.1.5.3. Argentina
    13.1.5.4. Venezuela
    13.1.5.5. Rest of Latin America
  13.1.6. Latin America Infectious Disease Diagnostics Market- Opportunity Analysis Index - By Test Type, By Product Type Type, By Infection Type, By End User, and Country, 2017 – 2023
  13.1.7. Latin America Infectious Disease Diagnostics Market Dynamics – Trends

14. MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

  14.1.1. Test Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
    14.1.1.1. Imaging Test
    14.1.1.2. Magnetic Resonance Imaging (MRI)
    14.1.1.3. X-ray
    14.1.1.4. Computed tomography (C.T)
    14.1.1.5. Laboratory Tests
      14.1.1.5.1. Blood Tests
      14.1.1.5.2. Urine Tests
      14.1.1.5.3. Stool Tests
      14.1.1.5.4. Spinal Tap
      14.1.1.5.5. Throat Swabs
    14.1.1.6. Biopsies
    14.1.1.7. Others
  14.1.2. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    14.1.2.1. Assay Kits and Consumables
    14.1.2.2. Instruments
    14.1.2.3. Services
  14.1.3. Infection Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    14.1.3.1. Viral
    14.1.3.2. Bacterial
    14.1.3.3. Fungal
    14.1.3.4. Sexually Transmitted Infectious Diseases
    14.1.3.5. Gastrointestinal
    14.1.3.6. Others
  14.1.4. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    14.1.4.1. Hospitals
    14.1.4.2. Diagnostic laboratories
    14.1.4.3. Home Healthcare
    14.1.4.4. Ambulatory Clinics
    14.1.4.5. Others
  14.1.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
    14.1.5.1. Gulf Cooperation Council (GCC) Countries
    14.1.5.2. Israel
    14.1.5.3. South Africa
    14.1.5.4. Rest of MEA
  14.1.6. MEA Infectious Disease Diagnostics Market- Opportunity Analysis Index - By Test Type, By Product Type Type, By Infection Type, By End User, and Country, 2017 – 2023
  14.1.7. MEA Infectious Disease Diagnostics Market Dynamics – Trends

15. COMPETITION LANDSCAPE

15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Drug & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
  15.2.1. F. Hoffmann-La Roche Ltd. (Switzerland)
  15.2.2. bioMérieux SA (France)
  15.2.3. Thermo Fischer Scientific (U.S.)
  15.2.4. Abbott Laboratories (U.S.)
  15.2.5. Bio-Rad Laboratories Inc. (U.S.)
  15.2.6. Becton, Dickinson & Company (U.S.)
  15.2.7. DiaSorin S.p.A. (Italy)

16. RESEARCH METHODOLOGY

17. KEY ASSUMPTIONS AND ACRONYMS